U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07123428) titled 'Single and Multiple Ascending Doses and Food Effect Study of TRD205 in Healthy Volunteers' on Jan. 19, 2024.
Brief Summary: This is a Phase I clinical study to evaluate the safety, tolerability, and pharmacokinetics of TRD205 after single and multiple doses and to evaluate the effect of food on TRD205 in healthy adult subjects.
Study Start Date: Jan. 26, 2024
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: TRD205
TRD205 tablet
DRUG: Placebo
TRD205 placebo tablet
Recruitment Status: COMPLETED
Sponsor: Beijing Tide Pharmaceutical Co., Ltd
Disclaimer: Curated by HT Syndication....